Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids

Vanessa Shih, Erika Banks, Nicole G. Bonine, Amanda Harrington, Dana Stafkey-Mailey, Binglin Yue, Jiatao Michael Ye, Rupali M. Fuldeore, Patrick Gillard

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Objective: To perform a retrospective, matched-cohort, longitudinal evaluation of annual pre- and post-diagnosis costs incurred among women with uterine fibroids (UF) (cases) compared to controls without UF. Methods: Data were derived from the IBM Watson Health MarketScan Commercial Claims and Encounters and Medicaid Multi-State databases. Women aged 18–64 years with ≥1 inpatient or outpatient medical claim with an initial UF diagnosis (index date) from 1 January 2010 to 31 December 2014 were included. Healthcare resource utilization (HCRU) data including pharmacy, outpatient and inpatient hospital claims were collected for 1 year pre-index and ≤5 years post-index. All-cause costs (adjusted to 2017 $US) were compared between cases and controls using multivariable regression models. Results: Analysis included 205,098 (Commercial) and 24,755 (Medicaid) case–control pairs. HCRU and total all-cause healthcare costs were higher for cases versus controls during the pre-index year and all years post-index. Total unadjusted mean all-cause costs were $1197 higher (p <.0001; Commercial) and $2813 higher (standardized difference 0.08; Medicaid) for cases during the pre-index year. Total adjusted mean all-cause costs in the first year post-index were $14,917 for cases versus $5717 for controls in the Commercial population, and $20,244 versus $10,544, respectively, in the Medicaid population. In Years 2–5 post-index, incremental mean adjusted total costs decreased, but remained significantly higher for cases versus controls at all time points in both populations (all p <.05). Conclusions: Costs were higher for women with UF compared to women without UF during the pre-index year and over 5 years post-index; differences were greatest in the first year post-index.

Original languageEnglish (US)
Pages (from-to)1925-1935
Number of pages11
JournalCurrent medical research and opinion
Volume35
Issue number11
DOIs
StatePublished - Nov 2 2019

Keywords

  • Cost
  • economic burden
  • healthcare resource utilization
  • leiomyomata
  • uterine fibroids

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids'. Together they form a unique fingerprint.

  • Cite this